The Use of Dermabond Versus Standard Staple for Wound Closure in Children With Neuromuscular Scoliosis Undergoing Spinal Deformity Correction Surgery
NCT ID: NCT01135940
Last Updated: 2016-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
80 participants
INTERVENTIONAL
2010-05-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Analysis of Sutures for Fascial Closure in Spinal Surgery
NCT03533595
Fusionless Treatment of Idiopathic Scoliosis With the SCOLI-TETHER System During The Growth Period
NCT04992845
Vertebral Augmentation With Kyphoplasty vs Nonsurgical Mgmt for Vertebral Body Compression Fractures
NCT01175278
Combined Therapy for Cervical Disc Herniation
NCT06995066
A New Spinal Orthosis for Adolescent Idiopathic Scoliosis
NCT03825159
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. To explore whether there is a difference in the cosmetic result of the wound closure as measured by the Hollander wound evaluation scale. Our hypothesis is that the Dermabond group will have a better cosmetic result. Secondary outcome
3. To explore whether there is a difference in the time for final wound closure. Our hypothesis is that the Dermabond group will have a shorter time for final wound closure. Secondary outcome
4. To explore whether there is a difference in mean caregiver/parental satisfaction scores as measured by a visual analog scale. Our hypothesis is that parental satisfaction will be higher in the Dermabond group. Secondary outcome
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
2-octylcyanoacrylate (Dermabond) closure
2-octylcyanoacrylate (Dermabond) closure
Standard procedure for closure of adipose/ subcutaneous layers. The subcuticular layer will be closed with a continuous 2-0 vicryl suture which will then be followed by Dermabond closure.
2
Standard staple closure
Standard staple closure
Standard procedure for closure of adipose/ subcutaneous layers followed by staple closure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
2-octylcyanoacrylate (Dermabond) closure
Standard procedure for closure of adipose/ subcutaneous layers. The subcuticular layer will be closed with a continuous 2-0 vicryl suture which will then be followed by Dermabond closure.
Standard staple closure
Standard procedure for closure of adipose/ subcutaneous layers followed by staple closure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* neuromuscular scoliosis
* undergoing posterior spinal instrumentation and fusion (one stage)
Exclusion Criteria
* previous history of spinal surgery
* previous incision over the operative site
* history of keloid formation
* allergy to superglue
* use of anticoagulation therapy
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BCCH Telethon Grant
UNKNOWN
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Firoz Miyanji, MD, FRCSC
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia
Christopher W. Reilly, MD, FRCSC
Role: STUDY_DIRECTOR
University of British Columbia
Kishore Mulpuri, MBBS, MS
Role: STUDY_DIRECTOR
University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
British Columbia Children's Hospital Department of Orthopaedics
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H10-00179
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.